...
首页> 外文期刊>Diagnostic microbiology and infectious disease >Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.
【24h】

Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.

机译:口服制剂对儿童肺炎链球菌分离株的活性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

An in vitro study of the activity of 10 oral agents against 153 pediatric isolates of Streptococcus pneumoniae identified moxifloxacin and levofloxacin as the most active agents regardless of penicillin or macrolide susceptibility. Moxifloxacin inhibited all strains at 0.25 &mgr;g/ml and was 8- to 16-fold more potent than levofloxacin.
机译:一项针对10种口服药物针对153例肺炎链球菌的活性进行的体外研究表明,无论青霉素或大环内酯类药物的敏感性如何,莫西沙星和左氧氟沙星都是最有效的药物。莫西沙星以0.25μg/ ml抑制所有菌株,效力比左氧氟沙星高8至16倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号